AR51 (12, 10)

BIOLOGICAL2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Bacterial Infections; Virus Diseases

Phase 2

A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003)

CompletedNCT00551915

Merck Sharp & Dohme LLCBacterial Infections; Virus Diseases

Start: 2001-05-31End: 2003-01-31Updated: 2015-10-30

A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002)

CompletedNCT00551629

Merck Sharp & Dohme LLCBacterial Infections; Virus Diseases

Start: 2001-05-31End: 2003-03-31Updated: 2015-10-30